Skip to main content
letter
. 2020 May;105(5):e221–e224. doi: 10.3324/haematol.2019.230193

Figure 1.

Figure 1

Morphologic characteristics of the bone marrow biopsy findings. (A) Patient with post-polycythemia myelofibrosis who developed 7% bone marrow blasts (group IB-2). CD34 highlights an increase in blasts (insert). (B) Patient with post-polycythemia myelofibrosis who developed accelerated phase (group AP). (C) Patient with polycythemia vera with neutrophilic progression (group OP). (D) Patient with primary myelofibrosis with monocytic progression (group OP).